CN Patent

CN119486723A — 使用安非他酮和右美沙芬的组合治疗右美沙芬的弱代谢者

Assigned to Antecip Bioventures II LLC · Expires 2025-02-18 · 1y expired

What this patent protects

本文公开了一种用右美沙芬和安非他酮的组合治疗神经系统病状的方法。该方法旨在用于患有神经系统病状或精神病状诸如重度抑郁症且为CYP2D6弱代谢者的患者。

USPTO Abstract

本文公开了一种用右美沙芬和安非他酮的组合治疗神经系统病状的方法。该方法旨在用于患有神经系统病状或精神病状诸如重度抑郁症且为CYP2D6弱代谢者的患者。

Drugs covered by this patent

Patent Metadata

Patent number: CN119486723A
Jurisdiction: CN
Classification: —
Expires: 2025-02-18
Drug substance claim: No
Drug product claim: No
Assignee: Antecip Bioventures II LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.